These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 12682635

  • 1. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
    Derksen PW, de Gorter DJ, Meijer HP, Bende RJ, van Dijk M, Lokhorst HM, Bloem AC, Spaargaren M, Pals ST.
    Leukemia; 2003 Apr; 17(4):764-74. PubMed ID: 12682635
    [Abstract] [Full Text] [Related]

  • 2. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
    Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST.
    Blood; 2002 Feb 15; 99(4):1405-10. PubMed ID: 11830493
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C.
    Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233
    [Abstract] [Full Text] [Related]

  • 4. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC, Fan S, Walter KA, Abounader R, Williams JA, Rosen EM, Laterra J.
    Cancer Res; 2000 Aug 01; 60(15):4277-83. PubMed ID: 10945642
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
    Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP.
    Oncogene; 2002 Mar 28; 21(14):2201-11. PubMed ID: 11948403
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O, Cantley LC.
    Exp Cell Res; 2004 Jul 01; 297(1):224-34. PubMed ID: 15194438
    [Abstract] [Full Text] [Related]

  • 8. Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.
    Tjin EP, Groen RW, Vogelzang I, Derksen PW, Klok MD, Meijer HP, van Eeden S, Pals ST, Spaargaren M.
    Blood; 2006 Jan 15; 107(2):760-8. PubMed ID: 16189274
    [Abstract] [Full Text] [Related]

  • 9. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Jankowski K, Kucia M, Wysoczynski M, Reca R, Zhao D, Trzyna E, Trent J, Peiper S, Zembala M, Ratajczak J, Houghton P, Janowska-Wieczorek A, Ratajczak MZ.
    Cancer Res; 2003 Nov 15; 63(22):7926-35. PubMed ID: 14633723
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR.
    Exp Hematol; 1998 Aug 15; 26(9):885-94. PubMed ID: 9694510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H, Holt RU, Rø TB, Fagerli UM, Hjorth-Hansen H, Baykov V, Christensen JG, Waage A, Sundan A, Børset M.
    Clin Cancer Res; 2004 Oct 01; 10(19):6686-94. PubMed ID: 15475459
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
    Pene F, Claessens YE, Muller O, Viguié F, Mayeux P, Dreyfus F, Lacombe C, Bouscary D.
    Oncogene; 2002 Sep 26; 21(43):6587-97. PubMed ID: 12242656
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor promotes cell proliferation and inhibits progesterone secretion via PKA and MAPK pathways in a human granulosa cell line.
    Taniguchi F, Harada T, Deura I, Iwabe T, Tsukihara S, Terakawa N.
    Mol Reprod Dev; 2004 Jul 26; 68(3):335-44. PubMed ID: 15112327
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C-betaII represses hepatocyte growth factor-induced invasion by preventing the association of adapter protein Gab1 and phosphatidylinositol 3-kinase in melanoma cells.
    Oka M, Kikkawa U, Nishigori C.
    J Invest Dermatol; 2008 Jan 26; 128(1):188-95. PubMed ID: 17625596
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP.
    Invest Ophthalmol Vis Sci; 2000 Jun 26; 41(7):1885-93. PubMed ID: 10845613
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V.
    Oncogene; 2002 Apr 04; 21(15):2309-19. PubMed ID: 11948414
    [Abstract] [Full Text] [Related]

  • 19. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL, Navolanic PM, Steelman LS, Shelton JG, Moye PW, Lee JT, Franklin RA, Mirza A, McMahon M, White MK, McCubrey JA.
    Leukemia; 2003 Jun 04; 17(6):1058-67. PubMed ID: 12764369
    [Abstract] [Full Text] [Related]

  • 20. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
    Slørdahl TS, Denayer T, Moen SH, Standal T, Børset M, Ververken C, Rø TB.
    Eur J Haematol; 2013 Nov 04; 91(5):399-410. PubMed ID: 23952536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.